Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest marketbeat.com · about 9 hours ago

Krystal Biotech Q2 Earnings Call Highlights

Krystal Biotech NASDAQ: KRYS reported second-quarter 2026 net revenue of $119.2 million from global sales of VYJUVEK, up 24% from $96 million in the prior-year period, as the company expanded treatment access for patients with dystrophic epidermolysis bullosa, or DEB, in the United States and overseas.

Stocks

More recent coverage

Page 51
MAR marketbeat.com · about 9 hours ago

Marriott International Q2 Earnings Call Highlights

Marriott International NASDAQ: MAR reported second-quarter results that exceeded its prior expectations, driven by global revenue per available room growth, expanding fee revenue and continued portfolio growth. The company raised its full-year 2026 outlook for global RevPAR, gross fee revenue, adjusted EBITDA and adjusted diluted earnings per share.

BE seekingalpha.com · about 9 hours ago

Bloom Energy: Impressive Growth And Operating Leverage Create A Better Set-Up

Bloom Energy has accelerated revenue growth, with Q2 sales up 165% to $1.07 billion and gross margins exceeding 33%. Bloom Energy raised the full-year guidance: sales to $3.9–$4.2 billion and non-GAAP operating profit to $800–$900 million, reflecting strong operating leverage. Valuation has compressed, with shares now at ~16x sales and ~75x earnings, down from more demanding multiples last quarter.

SRAD marketbeat.com · about 9 hours ago

Sportradar Group Q2 Earnings Call Highlights

Sportradar Group NASDAQ: SRAD reported second-quarter revenue growth of 19% as demand for its betting content, streaming, data and engagement products remained strong, while the company lowered its full-year outlook to reflect slower traditional U.S. sportsbook growth, regulatory and tax headwinds in some international markets, and timing delays for prediction-market agreements.

SUPN marketbeat.com · about 9 hours ago

Supernus Pharmaceuticals Q2 Earnings Call Highlights

Supernus Pharmaceuticals NASDAQ: SUPN and Indivior Pharmaceuticals announced a proposed all-stock, tax-free merger of equals that would create a central nervous system-focused biopharmaceutical company with approximately $2.2 billion in pro forma trailing 12-month net revenue as of June 30, 2026.

TGTX marketbeat.com · about 9 hours ago

TG Therapeutics Q2 Earnings Call Highlights

TG Therapeutics NASDAQ: TGTX reported second-quarter 2026 revenue of $240 million and raised its full-year sales outlook for BRIUMVI, its treatment for relapsing multiple sclerosis, as the company cited record new patient starts, continued prescriber expansion and higher-than-expected treatment persistence.

PODD prnewswire.com · about 9 hours ago

Robbins LLP Reminds Insulet Corporation (NASDAQ: PODD) Investors Who Suffered Significant Losses of the Securities Fraud Class Action

Lead Plaintiff Deadline: August 31, 2026 SAN DIEGO, Aug. 3, 2026 /PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"). The lawsuit alleges that Insulet made materially false or misleading statements regarding its manufacturing controls and the safety and reliability of its insulin delivery products.

GME invezz.com · about 9 hours ago

GameStop stock slides after $1.4B debt-for-stock swap raises dilution concerns

GameStop shares fell 10% on Monday after the video game retailer announced plans to exchange $1.4 billion worth of convertible debt for equity, a move that will substantially reduce its long-term debt but dilute existing shareholders. The company said certain noteholders would swap about $400 million of notes due in 2030 and $1 billion of notes due in 2032 for newly issued shares.

EQPT globenewswire.com · about 9 hours ago

EquipmentShare Investors With Significant Losses Should Contact Robbins LLP for Information About Leading the EQPT Class Action Lawsuit

SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a securities class action has been filed on behalf of shareholders who purchased or otherwise acquired EquipmentShare.com, Inc. (NASDAQ: EQPT) securities: (1) Class A common stock issued in connection with the Company's January 2026 initial public offering (“IPO”), or (2) EquipmentShare securities between January 23, 2026 and June 23, 2026, inclusive (the “Class Period”). The lawsuit alleges that EquipmentShare.com, Inc. made false and misleading statements and omissions concerning undisclosed related-party transactions and its financial condition in connection with its IPO and during the Class Period.

DEFI globenewswire.com · about 9 hours ago

Hashdex Announces Closure of Hashdex Bitcoin ETF

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Hashdex Asset Management Ltd. (“Hashdex”), as sponsor (the “Sponsor”) of Hashdex Commodities Trust (the “Trust”), today announced plans to close and liquidate the Hashdex Bitcoin ETF (NYSE Arca: DEFI) (the “Fund”), the sole series of the Trust. Assets under management of the Fund as of July 30, 2026, were approximately $14.7 million. Hashdex continues to manage over $200 million of assets in products available to U.S. investors.

← Newer
Older →